sexual dysfunction

Best of AUA 2015: PCa surveillance, surgical controversies create buzzUrology Times’ “Best of AUA 2015” report provides a guide to the meeting’s take-home messages in 15 therapeutic areas—an information-packed, condensed summary of the top papers and presentations.
State of Urology: Our experts' top picks for AUA 2015To help you maximize your AUA experience, Urology Times’ editorial board and other thought leaders have pored over hundreds of abstracts to identify the key trends and can’t-miss research from this year’s meeting.
Data confirm quick erectogenic effect of ED agentResults of a randomized, double-blind, placebo-controlled, phase IV study provide further confirmation that the erectogenic effect of the phosphodiesterase-type-5 inhibitor avanafil (Stendra) has a quick onset.
Low Estrogen could mean low Testosterone (VIDEO)Low testosterone is often blamed for a lower sex drive and potentially dangerous fat accumulation in men, however researchers from Massachusetts General Hospital report that a lack of estrogen is also to blame. Video provided by Renal & Urology News.
Urology Product Preview: Testosterone agent meets efficacy endpoint in phase III studiesDrugs and devices in the pipeline form Clarus Therapeutics, Nymox Pharmaceutical, Bioniche Life Sciences, Repros Therapeutics, BioLight Life Sciences Investments/Micromedic Technologies, Cubist Pharmaceuticals, Takeda Pharmaceutical, H. Lundbeck A/S, Transplant Genomics, Orion, Bayer, and Roche.
AUA 2014: Studies shine light on new PCa tests, TRT safetyIn our “Best of AUA” report, Urology Times’ editors and writers present the AUA annual meeting’s take-home messages in 15 therapeutic areas.
Best of AUA 2014: Sexual Function/Dysfunction
Best of AUA 2014: Sexual Function/DysfunctionLandon Trost, MD, presents the take home messages on sexual function/dysfunction from the AUA annual meeting in Orlando, FL, including studies of clostridium collagenase histolyticum (CCH [XIAFLEX]).
Clinical hypogonadism and the urologist’s role: Primum non nocereI consider urology to be a very unique field, one that I am lucky to be part of. Recently, though, I have begun to wonder whether the medical community (not necessarily the urology community) has been too quick to embrace the widespread use of testosterone replacement therapy.
Prosthesis may offer relief from intractable priapismMen with intractable priapism obtained immediate pain relief with few complications after implantation of a malleable penile prosthesis, data from a small clinical series showed.
Estradiol boosts libido in men receiving testosteroneA new study suggests that the role estrogen plays in influencing male libido may be more significant than previously thought. The findings carry implications for a variety of clinical situations, ranging from the use of testosterone replacement to boost flagging libido and androgen therapies in men with prostate cancer.